Steven W. Poser
Concise review: Reprogramming, behind the scenes: noncanonical neural stem cell signaling pathways reveal new, unseen regulators of tissue plasticity with therapeutic implications
Poser, Steven W.; Chenoweth, Josh G.; Colantuoni, Carlo; Masjkur, Jimmy; Chrousos, George; Bornstein, Stefan R.; McKay, Ronald D.; Androutsellis-Theotokis, Andreas
Josh G. Chenoweth
Stefan R. Bornstein
Ronald D. McKay
Interest is great in the new molecular concepts that explain, at the level of signal transduction, the process of reprogramming. Usually, transcription factors with developmental importance are used, but these approaches give limited information on the signaling networks involved, which could reveal new therapeutic opportunities. Recent findings involving reprogramming by genetic means and soluble factors with well-studied downstream signaling mechanisms, including signal transducer and activator of transcription 3 (STAT3) and hairy and enhancer of split 3 (Hes3), shed new light into the molecular mechanisms that might be involved. We examine the appropriateness of common culture systems and their ability to reveal unusual (noncanonical) signal transduction pathways that actually operate in vivo. We then discuss such novel pathways and their importance in various plastic cell types, culminating in their emerging roles in reprogramming mechanisms. We also discuss a number of reprogramming paradigms (mouse induced pluripotent stem cells, direct conversion to neural stem cells, and in vivo conversion of acinar cells to b-like cells). Specifically for acinar-to-b-cell reprogramming paradigms, we discuss the common view of the underlying mechanism (involving the Janus kinase-STAT pathway that leads to STAT3-tyrosine phosphorylation) and present alternative interpretations that implicate STAT3-serine phosphorylation alone or serine and tyrosine phosphorylation occurring in sequential order. The implications for drug design and therapy are important given that different phosphorylation sites on STAT3 intercept different signaling pathways. We introduce a new molecular perspective in the field of reprogramming with broad implications in basic, biotechnological, and translational research.
Poser, S. W., Chenoweth, J. G., Colantuoni, C., Masjkur, J., Chrousos, G., Bornstein, S. R., …Androutsellis-Theotokis, A. (2015). Concise review: Reprogramming, behind the scenes: noncanonical neural stem cell signaling pathways reveal new, unseen regulators of tissue plasticity with therapeutic implications. STEM CELLS, 4(11), doi:10.5966/sctm.2015-0105
|Journal Article Type||Article|
|Acceptance Date||Jul 8, 2015|
|Online Publication Date||Sep 14, 2015|
|Publication Date||Nov 1, 2015|
|Deposit Date||May 12, 2017|
|Peer Reviewed||Peer Reviewed|
|Keywords||Cellular reprogramming; Cellular transdifferentiation; Induced pluripotent stem cells; Signal transduction; STAT3 transcription factor; Hes3 protein; Pancreatic islets|
|Copyright Statement||Copyright information regarding this work can be found at the following address: http://eprints.nottingham.ac.uk/end_user_agreement.pdf|
This file is under embargo due to copyright reasons.
You might also like
Hes3 expression in the adult mouse brain is regulated during demyelination and remyelination
The effects of stress on brain and adrenal stem cells
STAT3-Ser/Hes3 signaling: a new molecular component of the neuroendocrine system?